prasugrel
UkraineDrugs containing this active substance
-
The drug is prescribed for adults with acute coronary syndrome (unstable angina or myocardial infarction) in combination with acetylsalicylic acid to prevent cardiovascular complications during coronary intervention.
Form: tablets, film-coated
Active substance Dosage prasugrel 5 mg ATC: B01AC22
Manufacturer: PLIVA Hrvatska d.o.o. (full-cycle manufacturing; batch control (X-ray diffraction method))
-
The drug is prescribed for adults with acute coronary syndrome (unstable angina or myocardial infarction) in combination with acetylsalicylic acid to prevent cardiovascular complications during coronary intervention.
Form: tablets, film-coated
Active substance Dosage prasugrel 10 mg ATC: B01AC22
Manufacturer: PLIVA Hrvatska d.o.o. (full-cycle manufacturing; batch control (X-ray diffraction method))
-
The drug is indicated for adults with acute coronary syndrome (unstable angina or myocardial infarction) in combination with acetylsalicylic acid (ASA) to prevent atherothrombotic events during medical interventions on the coronary arteries.
Form: tablets, film-coated
Active substance Dosage prasugrel 10 mg ATC: B01AC22
Manufacturer: Neuraxpharm Farmacéuticas, S.L.
-
The drug is intended for adults with acute coronary syndrome (unstable angina or myocardial infarction) in combination with acetylsalicylic acid to prevent atherothrombotic complications during coronary intervention.
Form: tablets, film-coated
Active substance Dosage prasugrel 10 mg ATC: B01AC22
Manufacturer: PJSC "Kyivmedpreparat" (manufacturing in bulk form for manufacturer "Neuraxpharm Farmaceuticas, S.L.", Spain)
-
The drug is prescribed for adults to prevent cardiovascular complications (such as myocardial infarction, stroke, or death from cardiovascular disease) in patients with acute coronary syndrome undergoing percutaneous coronary intervention.
Form: tablets, film-coated
Active substance Dosage prasugrel 5 mg ATC: B01AC22
Manufacturer: Neuraxpharm Farmaceuticas S.L. (Manufacturer responsible for production, packaging, quality control and batch release)
-
The drug is prescribed for adults to prevent cardiovascular complications (such as myocardial infarction, stroke, or death from cardiovascular disease) in patients with acute coronary syndrome undergoing percutaneous coronary intervention.
Form: tablets, film-coated
Active substance Dosage prasugrel 10 mg ATC: B01AC22
Manufacturer: Neuraxpharm Farmaceuticas S.L. (Manufacturer responsible for production, packaging, quality control and batch release)